Strategies to Optimize the Dosage Form Design Process to Create Better Treatments
Summary: Traditional dosage form design and development is largely driven by cost and timelines. However, there are several additional considerations that are often overlooked, impacting the long-term success of a drug product. Enlisting the help of expert partners to advise on these considerations could increase the likelihood of drug product success.
In this webinar, co-organized with Bionow, experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments. The experts discuss Catalent’s holistic development approach that combines the API’s biopharmaceutic properties, PBPK modeling, manufacturability, and target patient characteristics to support decision-making during the dosage form design process.